Breaking News Instant updates and real-time market news.

2020-11-17 08:03:54 BYSI BeyondSpring $15.81 / -1.51 (-8.72%) 08:03 11/17/20 11/17 08:03 11/17/20 08:03	BeyondSpring reports Q3 EPS (37c), consensus (54c) "We were thrilled to announce positive top-line data in our pivotal Phase 3 study demonstrating plinabulin in combination with pegfilgrastim provides superior benefits for patients in preventing chemotherapy-induced neutropenia compared with peg alone. Results show combination plinabulin + peg's ability to reduce infection and hospitalization rates after chemotherapy, allowing for the potential for patients to continue receiving life-saving treatments. This means patients may potentially receive more stable doses, longer sustained cycles and the strongest regimens possible resulting in potential survival benefit," said Dr. Lan Huang, co-founder, chairperson and chief executive officer of BeyondSpring. "We expect to file a New Drug Application for CIN, plinabulin's first indication, in the U.S. in early 2021, soon followed by an NDA submission in China and look forward bringing this important therapy to market."	19 Jun
BYSI BeyondSpring $15.81 / -1.51 (-8.72%) 06/15/20 William Blair BeyondSpring can 'disrupt' $6.5B neutropenia market, says William Blair 06/15/20 H.C. Wainwright BeyondSpring price target raised to $46 from $30 at H.C. Wainwright 06/09/20 H.C. Wainwright BeyondSpring data strengthen profile for Plinabulin, says H.C. Wainwright 02/07/20 Fly Intel: Top five analyst initiations

2020-11-17 08:03:54

BYSI

BeyondSpring

$15.81 / -1.51 (-8.72%)

08:03

11/17/20

11/17

08:03

11/17/20

08:03

BeyondSpring reports Q3 EPS (37c), consensus (54c)

"We were thrilled to announce positive top-line data in our pivotal Phase 3 study demonstrating plinabulin in combination with pegfilgrastim provides superior benefits for patients in preventing chemotherapy-induced neutropenia compared with peg alone. Results show combination plinabulin + peg's ability to reduce infection and hospitalization rates after chemotherapy, allowing for the potential for patients to continue receiving life-saving treatments. This means patients may potentially receive more stable doses, longer sustained cycles and the strongest regimens possible resulting in potential survival benefit," said Dr. Lan Huang, co-founder, chairperson and chief executive officer of BeyondSpring. "We expect to file a New Drug Application for CIN, plinabulin's first indication, in the U.S. in early 2021, soon followed by an NDA submission in China and look forward bringing this important therapy to market."

19
Jun

BYSI BeyondSpring

$15.81 / -1.51 (-8.72%)

06/15/20 William Blair: BeyondSpring can 'disrupt' $6.5B neutropenia market, says William Blair

06/15/20 H.C. Wainwright: BeyondSpring price target raised to $46 from $30 at H.C. Wainwright

06/09/20 H.C. Wainwright: BeyondSpring data strengthen profile for Plinabulin, says H.C. Wainwright

02/07/20: Fly Intel: Top five analyst initiations

TODAY'S FREE FLY STORIES

Recommendations	Denison Mines price target raised to C$1.55 from C$1 at TD Securities » 11:27 02/25/21 02/25 11:27 02/25/21 11:27 DNN Denison Mines $1.12 / -0.035 (-3.04%) TD Securities analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Syndicate Options DNN Denison Mines $1.12 / -0.035 (-3.04%) 12/01/20 Denison Mines announces decision to adopt freeze wall for Phoenix ISR mining 11/09/20 Denison Mines to resume Wheeler River formal environmental assessment process 10/28/20 Denison Mines completes ISR field program at Wheeler River DNN Denison Mines $1.12 / -0.035 (-3.04%) 02/10/21 Raymond James Denison Mines price target raised to C$1.20 from C$1.15 at Raymond James 01/21/21 Canaccord Denison Mines price target raised to C$1.10 from C$0.90 at Canaccord 01/15/21 Raymond James Denison Mines price target raised to C$1.15 from C$0.95 at Raymond James 01/05/21 TD Securities Denison Mines downgraded to Hold from Speculative Buy at TD Securities 26 Mar DNN Denison Mines $1.12 / -0.035 (-3.04%) 02/18/21 Unusually active option classes on open February 18th 02/18/21 Largest borrow rate increases among liquid names 02/17/21 Notable open interest changes for February 17th 02/12/21 Notable open interest changes for February 12th
General news	3-Month Bill Announcement Offering Amount data reported » 11:27 02/25/21 02/25 11:27 02/25/21 11:27 3-Month Bill Announcement… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial
General news	6-Month Bill Announcement Offering Amount data reported » 11:27 02/25/21 02/25 11:27 02/25/21 11:27 6-Month Bill Announcement… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Recommendations	Capstone Mining price target raised to C$4.75 from C$3.50 at TD Securities » 11:27 02/25/21 02/25 11:27 02/25/21 11:27 CSFFF Capstone Mining $0.00 / + (+0.00%) TD Securities analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research CSFFF Capstone Mining $0.00 / + (+0.00%) 11:17 Today National Bank Capstone Mining price target raised to C$4.50 from C$3.35 at National Bank 02/03/21 National Bank Capstone Mining price target raised to C$3.35 from C$3.25 at National Bank 01/28/21 Scotiabank Capstone Mining price target raised to C$4.25 from C$4 at Scotiabank 01/20/21 BMO Capital Capstone Mining price target raised to C$3 from C$2.60 at BMO Capital
Conference/Events	SailPoint to host analyst day » 11:26 02/25/21 02/25 11:26 02/25/21 11:26 SAIL SailPoint $57.80 / -1.82 (-3.05%) Analyst Day to be held on… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events SAIL SailPoint $57.80 / -1.82 (-3.05%) 02/18/21 SailPoint to acquire Intello, terms not stated 10/05/20 SailPoint to replace Sally Beauty in S&P 400 at open on 10/5 10/01/20 SailPoint rises 13.2% 10/01/20 SailPoint rises 13.8% SAIL SailPoint $57.80 / -1.82 (-3.05%) 02/16/21 Canaccord SailPoint price target raised to $70 from $53 at Canaccord 01/27/21 RBC Capital SailPoint price target raised to $68 from $55 at RBC Capital 01/27/21 Truist SailPoint price target raised to $65 from $55 at Truist 01/08/21 Morgan Stanley SailPoint price target raised to $71 from $63 at Morgan Stanley SAIL SailPoint $57.80 / -1.82 (-3.05%) 11/05/20 SailPoint sees FY20 adjusted EPS 27c-29c, consensus 11c 11/05/20 SailPoint sees Q4 adjusted EPS (2c)-(1c), consensus (4c) 11/05/20 SailPoint reports Q3 adjusted EPS 11c, consensus (5c) 11/05/20 Notable companies reporting after market close SAIL SailPoint $57.80 / -1.82 (-3.05%) 12/21/20 Analysts move to sidelines on SolarWinds following cyberattack 10/01/20 Fly Intel: Pre-market Movers 09/30/20 Fly Intel: After-Hours Movers 17:00 Today SailPoint - SAIL 02/26/21 SailPoint Technologies Holdings, Inc.

Recommendations	DREAM Unlimited price target raised to C$28 from C$25 at TD Securities » 11:26 02/25/21 02/25 11:26 02/25/21 11:26 DRUNF DREAM Unlimited $0.00 / + (+0.00%) TD Securities analyst Sam… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research DRUNF DREAM Unlimited $0.00 / + (+0.00%) 10/14/20 TD Securities DREAM Unlimited price target raised to C$25 from C$24 at TD Securities 08/17/20 TD Securities DREAM Unlimited price target raised to C$24 from C$23 at TD Securities 05/14/20 CIBC DREAM Unlimited price target lowered to C$12 from C$14 at CIBC
Recommendations	Centerra Gold price target raised to C$17 from C$16.50 at TD Securities » 11:26 02/25/21 02/25 11:26 02/25/21 11:26 CAGDF Centerra Gold $0.00 / + (+0.00%) TD Securities analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research CAGDF Centerra Gold $0.00 / + (+0.00%) 10/06/20 Centerra Gold confirms continuation of operations at Kumtor Mine CAGDF Centerra Gold $0.00 / + (+0.00%) 10:53 Today National Bank Centerra Gold price target lowered to C$20 from C$21.50 at National Bank 02/08/21 CIBC Centerra Gold downgraded to Neutral from Outperformer at CIBC 02/02/21 Credit Suisse Centerra Gold price target lowered to C$15.50 from C$16 at Credit Suisse 01/11/21 National Bank Centerra Gold price target raised to C$21.50 from C$20.50 at National Bank
Recommendations	Baytex Energy price target raised to C$1.30 from C$0.90 at TD Securities » 11:25 02/25/21 02/25 11:25 02/25/21 11:25 BTEGF Baytex Energy $0.00 / + (+0.00%) TD Securities analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research Events BTEGF Baytex Energy $0.00 / + (+0.00%) 10:51 Today National Bank Baytex Energy price target raised to C$1.75 from C$1.50 at National Bank 02/19/21 National Bank Baytex Energy price target raised to C$1.50 from C$1.00 at National Bank 01/14/21 Scotiabank Baytex Energy price target raised to C$1 from C$0.70 at Scotiabank 01/06/21 National Bank Baytex Energy price target raised to C$1 from C$0.75 at National Bank 11:00 Today Baytex Energy - BTEGF
Options	TripAdvisor call volume above normal and directionally bullish » 11:25 02/25/21 02/25 11:25 02/25/21 11:25 TRIP TripAdvisor $45.82 / -3.72 (-7.51%) Bullish option flow… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options TRIP TripAdvisor $45.82 / -3.72 (-7.51%) 02/18/21 TripAdvisor sees Q1 revenue, adjusted EBITDA roughly in line with 4Q20 02/18/21 TripAdvisor: January revenue performance dipped slightly relative to December 02/18/21 TripAdvisor entering 2021 'with optimism' 02/18/21 TripAdvisor CEO says 'pent up travel demand continues to grow' TRIP TripAdvisor $45.82 / -3.72 (-7.51%) 02/23/21 Wells Fargo TripAdvisor price target raised to $47 from $32 at Wells Fargo 02/22/21 DA Davidson TripAdvisor price target raised to $46 from $26 at DA Davidson 02/22/21 Stifel TripAdvisor price target raised to $39 from $26 at Stifel 02/22/21 Credit Suisse TripAdvisor price target raised to $31 from $25 at Credit Suisse TRIP TripAdvisor $45.82 / -3.72 (-7.51%) 02/18/21 TripAdvisor reports Q4 adjusted EPS (41c), consensus (25c) 02/18/21 Notable companies reporting after market close 11/06/20 TripAdvisor expects Q4 revenue to be modestly lower than Q3, consensus $174.93M 11/05/20 TripAdvisor reports Q3 adjusted EPS (17c), consensus (26c) TRIP TripAdvisor $45.82 / -3.72 (-7.51%) 10/23/20 TripAdvisor CEO welcomes DOJ move to look into Google, CNBC reports 09/29/20 Amazon gets into virtual tourism, with Amazon Explore, GeekWire reports TRIP TripAdvisor $45.82 / -3.72 (-7.51%) 01/08/21 Another Tesla upgrade among today's top calls on Wall Street 12/02/20 Fly Intel: Pre-market Movers 12/01/20 Pinterest, FedEx upgrades among today's top calls on Wall Street 10/24/20 Week in review: How Trump's policies moved stocks TRIP TripAdvisor $45.82 / -3.72 (-7.51%) 02/24/21 TripAdvisor call volume above normal and directionally bullish 01/08/21 Early notable gainers among liquid option names on January 8th 11/10/20 TripAdvisor call volume above normal and directionally bullish 10/22/20 TripAdvisor call volume above normal and directionally bullish
Conference/Events	Wedbush payments/IT services analyst holds an analyst/industry conference call » 11:25 02/25/21 02/25 11:25 02/25/21 11:25 PYPL PayPal $260.50 / -5.53 (-2.08%) Payments/IT Services… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options PYPL PayPal $260.50 / -5.53 (-2.08%) 02/17/21 PayPal CEO sells 10K shares of common stock 02/17/21 PayPal's Sarnoff sells 5,290 common shares 02/16/21 Lone Pine bought Snap and Carvana during Q4, exited PayPal 02/08/21 PayPal CEO sells 10K shares of common stock PYPL PayPal $260.50 / -5.53 (-2.08%) 02/16/21 BTIG PayPal price target raised to $345 from $300 at BTIG 02/12/21 Keefe Bruyette PayPal price target raised to $340 from $290 at Keefe Bruyette 02/12/21 Loop Capital PayPal price target raised to $321 from $291 at Loop Capital 02/12/21 Raymond James PayPal price target raised to $333 from $296 at Raymond James PYPL PayPal $260.50 / -5.53 (-2.08%) 02/16/21 Tiger Global bought DoorDash and 1Life during Q4, sold out of Alphabet 02/03/21 PayPal sees Q1 adjusted EPS growth of about 50%, consensus 99c 02/03/21 PayPal sees FY21 adjusted EPS up about 17%, consensus $4.54 02/03/21 PayPal reports Q4 adjusted EPS $1.08, consensus $1.00 PYPL PayPal $260.50 / -5.53 (-2.08%) 02/19/21 'Heard on the Street' highlights PayPal, Square among crypto-exposure names 02/12/21 PayPal not likely to invest cash in cryptocurrencies, CFO tells CNBC 02/11/21 PayPal sees EPS growing at 22% CAGR over five years, Bloomberg says 12/29/20 Beijing seeking larger stake in Jack Ma's businesses, WSJ reports PYPL PayPal $260.50 / -5.53 (-2.08%) 02/23/21 Fly Intel: What to watch in Square earnings report 02/12/21 The Intersection: Crypto and Wall Street This Week 02/04/21 Fly Intel: Wall Street's top stories for Thursday 02/04/21 Fly Intel: Wall Street's top stories at midday 12:00 Today Payments/IT Services PYPL PayPal $260.50 / -5.53 (-2.08%) 02/12/21 Unusually active option classes on open February 12th 02/04/21 Early notable gainers among liquid option names on February 4th 02/04/21 Notable open interest changes for February 4th 02/03/21 PayPal options imply 10.1% move in share price post-earnings

Conference/Events	1-800-Flowers.com participates in a conference call with Benchmark » 11:25 02/25/21 02/25 11:25 02/25/21 11:25 FLWS 1-800-Flowers.com $30.15 / -0.85 (-2.74%) Internet, Media &… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events FLWS 1-800-Flowers.com $30.15 / -0.85 (-2.74%) 01/28/21 1-800-Flowers.com not providing FY21 guidance 09/08/20 1-800-Flowers.com plans to hire more than 10,000 seasonal employees 09/01/20 Founder of 1-800-Flowers.com sells 845,000 shares of the company 08/27/20 1-800-Flowers.com partners with Universal Pictures for flower and film gift FLWS 1-800-Flowers.com $30.15 / -0.85 (-2.74%) 10/29/20 Benchmark 1-800-Flowers.com selloff brings 'excellent' opportunity, says Benchmark 08/28/20 Fly Intel: Top five analyst upgrades 08/28/20 DA Davidson 1-800-Flowers.com upgraded to Neutral from Underperform at DA Davidson 08/28/20 DA Davidson 1-800-Flowers.com upgraded to Neutral from Underperform at DA Davidson FLWS 1-800-Flowers.com $30.15 / -0.85 (-2.74%) 01/28/21 1-800-Flowers.com sees Q3 EPS (11c)-(9c), consensus (8c) 01/28/21 1-800-Flowers.com reports Q2 EPS $1.71, consensus $1.39 10/29/20 1-800-Flowers.com sees Q2 adjusted EPS growth 18%-23% y-o-y, consensus $1.31 10/29/20 1-800-Flowers.com reports Q1 adjusted EPS (10c), consensus (13c) FLWS 1-800-Flowers.com $30.15 / -0.85 (-2.74%) 10/29/20 Fly Intel: Wall Street's top stories for Thursday 10/29/20 Fly Intel: Wall Street's top stories at midday 08/27/20 Fly Intel: Pre-market Movers 12:00 Today 1-800-Flowers.com - FLWS 03/03/21 1-800-Flowers.com - FLWS
Conference/Events	Morgan Stanley autos/semis analysts hold an analyst/industry conference call » 11:25 02/25/21 02/25 11:25 02/25/21 11:25 EU Autos & Shared… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial
Recommendations	Royal Bank of Canada price target raised to C$123 from C$117 at National Bank » 11:24 02/25/21 02/25 11:24 02/25/21 11:24 RY Royal Bank of Canada $89.11 / -0.28 (-0.31%) National Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings RY Royal Bank of Canada $89.11 / -0.28 (-0.31%) 02/24/21 Royal Bank of Canada reports Q1 ROE of 18.6%, up 100 bps y/y 01/28/21 Alliance Data: Bread announces technology partnership with Royal Bank of Canada 12/04/20 RBC now accepting applications for Canada's expanded CEBA loan program 12/02/20 Royal Bank of Canada reports Q4 CET1 ratio 12.5%, up 40 bps vs. last year RY Royal Bank of Canada $89.11 / -0.28 (-0.31%) 08:45 Today Canaccord Royal Bank of Canada price target raised to C$123 from C$16 at Canaccord 02/18/21 Canaccord Canaccord upgrades Royal Bank to Buy on improved valuation 02/18/21 Canaccord Royal Bank of Canada upgraded to Buy from Hold at Canaccord 02/17/21 Scotiabank Royal Bank of Canada price target raised to C$129 from C$125 at Scotiabank RY Royal Bank of Canada $89.11 / -0.28 (-0.31%) 02/24/21 Royal Bank of Canada reports Q1 diluted EPS C$2.66, up 11% y/y 12/02/20 Royal Bank of Canada reports Q4 diluted EPS C$2.23 vs. C$2.18 a year ago 08/26/20 Royal Bank of Canada reports Q3 diluted EPS C$2.20, down 1% y/y
Recommendations	Hydro One price target lowered to C$31 from C$32 at National Bank » 11:23 02/25/21 02/25 11:23 02/25/21 11:23 HRNNF Hydro One $0.00 / + (+0.00%) National Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research HRNNF Hydro One $0.00 / + (+0.00%) 01/27/21 National Bank Hydro One price target raised to C$32 from C$31 at National Bank 01/13/21 CIBC Hydro One price target raised to C$33 from C$32 at CIBC 11/10/20 Credit Suisse Hydro One price target raised to C$32 from C$28 at Credit Suisse 11/09/20 CIBC Hydro One price target raised to C$32 from C$31 at CIBC
Conference/Events	Reinsurance Group management to meet virtually with Piper Sandler » 11:23 02/25/21 02/25 11:23 02/25/21 11:23 RGA Reinsurance Group $126.73 / -0.76 (-0.60%) Virtual Meeting to be… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Events RGA Reinsurance Group $126.73 / -0.76 (-0.60%) 02/04/21 Reinsurance Group to purchase Hodge Life Assurance, terms undisclosed RGA Reinsurance Group $126.73 / -0.76 (-0.60%) 01/29/21 Credit Suisse Reinsurance Group downgraded to Underperform from Neutral at Credit Suisse 01/06/21 Piper Sandler Reinsurance Group price target raised to $130 from $127 at Piper Sandler 12/16/20 Keefe Bruyette Reinsurance Group downgraded to Market Perform at Keefe Bruyette 11/11/20 JPMorgan Reinsurance Group downgraded to Neutral on Covid headwinds at JPMorgan RGA Reinsurance Group $126.73 / -0.76 (-0.60%) 02/08/21 Reinsurance Group reports Q4 adjusted EPS $1.19, consensus $1.06 11/05/20 Reinsurance Group reports Q3 adjusted EPS $3.51, consensus $1.80 02 Jun 02/26/21 Reinsurance Group

Recommendations	Goodfood Market price target lowered to C$13.75 from C$14.25 at National Bank » 11:23 02/25/21 02/25 11:23 02/25/21 11:23 GDDFF Goodfood Market $0.00 / + (+0.00%) National Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research GDDFF Goodfood Market $0.00 / + (+0.00%) 02/16/21 Goodfood Market announces $21M expansion of syndicated bank financing 01/27/21 Goodfood Market CFO Philippe Adam to depart 12/01/20 Goodfood Market announces C$46M syndicated bank financing 10/08/20 Goodfood Market launches Goodfood WOW same-day delivery service GDDFF Goodfood Market $0.00 / + (+0.00%) 01/14/21 National Bank Goodfood Market price target raised to C$14.25 from C$12.75 at National Bank 01/14/21 Scotiabank Goodfood Market price target raised to C$14 from C$11 at Scotiabank 01/08/21 Canaccord Goodfood Market price target raised to C$14.50 from C$12.50 at Canaccord 01/07/21 Raymond James Goodfood Market downgraded to Market Perform from Outperform at Raymond James
Conference/Events	Kaleido Biosciences management to meet virtually with JMP Securities » 11:20 02/25/21 02/25 11:20 02/25/21 11:20 KLDO Kaleido Biosciences $9.97 / +0.13 (+1.32%) Virtual Meeting to be… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Events Options KLDO Kaleido Biosciences $9.97 / +0.13 (+1.32%) 01/14/21 Kaleido Biosciences announces interim results of controlled study of KB109 01/04/21 Kaleido Biosciences completes enrollment of 350 subjects in KB109 study 11/02/20 Kaleido Biosciences sees cash runway into 2H21 11/02/20 Kaleido Biosciences announces anticipated milestones KLDO Kaleido Biosciences $9.97 / +0.13 (+1.32%) 02/09/21 Piper Sandler Kaleido Biosciences initiated with an Overweight at Piper Sandler 01/14/21 Chardan Kaleido Biosciences price target raised to $17.50 from $10 at Chardan 12/23/20 JMP Securities Kaleido Biosciences initiated with an Outperform at JMP Securities 10/14/20 JPMorgan Kaleido Biosciences resumed with an Underweight at JPMorgan KLDO Kaleido Biosciences $9.97 / +0.13 (+1.32%) 11/02/20 Kaleido Biosciences reports Q3 EPS (65c), consensus (63c) 04 Feb 02 Jun 02/26/21 Kaleido Biosciences KLDO Kaleido Biosciences $9.97 / +0.13 (+1.32%) 01/28/21 new option listings on January 28th
Conference/Events	Hillenbrand management to meet virtually with DA Davidson » 11:18 02/25/21 02/25 11:18 02/25/21 11:18 HI Hillenbrand $47.42 / -0.185 (-0.39%) Virtual Meeting to be… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events HI Hillenbrand $47.42 / -0.185 (-0.39%) 01/11/21 Idex Corp. acquires Abel Pumps from Hillenbrand for $103.5M in cash 01/11/21 Hillenbrand to sell ABEL Pumps to Idex Corp. for $103.5M in cash 01/04/21 Hillenbrand completes sale Red Valve business to DeZURIK 12/03/20 Hillenbrand raises quarterly dividend to 21.5c from 21.25c per share HI Hillenbrand $47.42 / -0.185 (-0.39%) 02/08/21 DA Davidson Hillenbrand price target raised to $52 from $46 at DA Davidson 02/04/21 Barrington Hillenbrand price target raised to $54 from $50 at Barrington 01/06/21 Barrington Imax and Sirius XM among Barrington's best ideas for 2021 11/16/20 DA Davidson Hillenbrand price target raised to $44 from $42 at DA Davidson HI Hillenbrand $47.42 / -0.185 (-0.39%) 02/03/21 Hillenbrand sees Q2 adjusted EPS 85c-95c, consensus 67c 02/03/21 Hillenbrand reports Q1 adjusted EPS 96c, consensus 67c 11/11/20 Hillenbrand sees Q1 EPS 65c-75c, consensus 42c 11/11/20 Hillenbrand reports Q4 EPS 92c, consensus 56c HI Hillenbrand $47.42 / -0.185 (-0.39%) 02/03/21 Fly Intel: After-Hours Movers 11/11/20 Fly Intel: After-Hours Movers 02/26/21 Hillenbrand
Conference/Events	Halozyme management to meet virtually with Cantor Fitzgerald » 11:17 02/25/21 02/25 11:17 02/25/21 11:17 HALO Halozyme $47.49 / -3.94 (-7.66%) Virtual Meeting to be… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events HALO Halozyme $47.49 / -3.94 (-7.66%) 02/01/21 Argenx to continue enrollment in ADHERE trial evaluating SC efgartigimod 01/15/21 Halozyme says Janssen receives FDA approval of Darzalex Faspro 12/23/20 Halozyme announces EC approval of Roche fixed-dose combination with Enhanze 12/07/20 Halozyme's Kelly sells 35,086 common shares HALO Halozyme $47.49 / -3.94 (-7.66%) 01/25/21 BMO Capital Halozyme price target raised to $65 from $56 at BMO Capital 01/21/21 Benchmark Halozyme price target raised to $59 from $46 at Benchmark 01/14/21 Piper Sandler Halozyme price target raised to $50 from $42 at Piper Sandler 01/11/21 Benchmark Phesgo EU approval/Horizon deal fuel Halozyme increased guidance, says Benchmark HALO Halozyme $47.49 / -3.94 (-7.66%) 02/23/21 Halozyme sees FY21 GAAP EPS $1.40-$1.55, consensus $1.70 02/23/21 Halozyme reports Q4 EPS 50c, consensus 53c 01/11/21 Halozyme sees FY21 GAAP EPS $1.40-$1.55, consensus $1.79 11/23/20 Halozyme raises FY20 EPS view to 90c-95c from 80c-85c, consensus 86c HALO Halozyme $47.49 / -3.94 (-7.66%) 02/23/21 Fly Intel: After-Hours Movers 02/02/21 Immunovant plunges after announcing voluntary hold of IMVT-1401 dosing 11/05/20 Fly Intel: After-Hours Movers 11/02/20 Fly Intel: After-Hours Movers 02/26/21 Halozyme
Recommendations	Capstone Mining price target raised to C$4.50 from C$3.35 at National Bank » 11:17 02/25/21 02/25 11:17 02/25/21 11:17 CSFFF Capstone Mining $0.00 / + (+0.00%) National Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research CSFFF Capstone Mining $0.00 / + (+0.00%) 02/03/21 National Bank Capstone Mining price target raised to C$3.35 from C$3.25 at National Bank 01/28/21 Scotiabank Capstone Mining price target raised to C$4.25 from C$4 at Scotiabank 01/20/21 BMO Capital Capstone Mining price target raised to C$3 from C$2.60 at BMO Capital 01/20/21 TD Securities Capstone Mining price target raised to C$3.50 from C$3 at TD Securities

Technical Analysis	NASDAQ market internals summary » 11:17 02/25/21 02/25 11:17 02/25/21 11:17 $NSD NASDAQ Market Internals $0.00 / + (+0.00%) Volume is above average… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Technical Analysis $NSD NASDAQ Market Internals $0.00 / + (+0.00%) 10:17 Today NASDAQ market internals summary 02/24/21 NASDAQ market internals summary 02/24/21 NASDAQ market internals summary 02/24/21 NASDAQ market internals summary
Technical Analysis	NYSE market internals summary » 11:16 02/25/21 02/25 11:16 02/25/21 11:16 $NYE NYSE Market Internals $0.00 / + (+0.00%) Volume is above average… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Technical Analysis $NYE NYSE Market Internals $0.00 / + (+0.00%) 10:16 Today NYSE market internals summary 02/24/21 NYSE market internals summary 02/24/21 NYSE market internals summary 02/24/21 NYSE market internals summary
General news	4-Week Bill Auction to be released at 11:30 11:15 02/25/21 02/25 11:15 02/25/21 11:15
General news	8-Week Bill Auction to be released at 11:30 11:15 02/25/21 02/25 11:15 02/25/21 11:15
Conference/Events	Amedisys management to meet virtually with Truist » 11:14 02/25/21 02/25 11:14 02/25/21 11:14 AMED Amedisys $268.23 / -13.13 (-4.67%) Virtual Meeting to be… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events AMED Amedisys $268.23 / -13.13 (-4.67%) 02/24/21 Amedisys promotes Christopher Gerard to COO, Scott Ginn to CFO 01/05/21 Amedisys, Option Care Health collaborate on COVID therapy access model 12/23/20 Amedisys announces up to $100M share repurchase plan AMED Amedisys $268.23 / -13.13 (-4.67%) 02/23/21 Benchmark Amedisys price target raised to $325 from $275 at Benchmark 02/08/21 Deutsche Bank Amedisys price target raised to $340 from $275 at Deutsche Bank 01/05/21 Truist Amedisys price target raised to $325 from $280 at Truist 11/03/20 Barclays Amedisys price target raised to $298 from $290 at Barclays AMED Amedisys $268.23 / -13.13 (-4.67%) 02/24/21 Amedisys sees FY21 adjusted EPS $6.25-$6.47, consensus $6.31 02/24/21 Amedisys reports Q4 adjusted EPS $1.49, consensus $1.47 10/28/20 Amedisys sees FY20 EPS $6.02- $6.08, consensus $4.98 10/28/20 Amedisys reports Q3 EPS $2.24, consensus $1.28 AMED Amedisys $268.23 / -13.13 (-4.67%) 02/24/21 Fly Intel: After-Hours Movers 03/02/21 2021 London Global Healthcare Virtual Conference 11:00 Today Amedisys - AMED 02/26/21 Amedisys 03/11/21 Amedisys

Events

Earnings calls, analyst events, roadshows and more

Today at 11:30

4-Week Bill Auction Government Event
Today at 11:30

8-Week Bill Auction Government Event
GMLP
Today at 11:30

Golar LNG Partners - GMLP Conference Calls
Today at 11:30

Electrical Equipment & Multi Industry Industry Meetings
TNK
Today at 12:00

Teekay Tankers - TNK Conference Calls
PLMR
Today at 12:00

Palomar - PLMR Conference Calls
CCAP
Today at 12:00

Crescent BDC - CCAP Conference Calls
FLWS
Today at 12:00

1-800-Flowers.com - FLWS Conference Calls
SRE
Today at 12:00

Sempra Energy - SRE Conference Calls
PNTG
Today at 12:00

The Pennant Group - PNTG Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	OUT X OUT Outfront Media Block Trade Managers: Morgan Stanley Priced at: $22.00 1.76M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BWAY X BWAY Brainsway Spot Secondary Managers: Oppenheimer Priced at: $8.50 4.62M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CCL X CCL Carnival Spot Secondary Managers: Goldman Sachs Priced at: $25.10 40.45M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PAVM X PAVM PAVmed Spot Secondary Managers: Cantor Fitzgerald Priced at: $4.60 9.8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SHOP X SHOP Shopify Spot Secondary Managers: Citi, Credit Suisse & Goldman Sachs Priced at: $1,315 1.18M Shares
Tues	DISCK X DISCK Discovery Inc. Block Trade Managers: Credit Suisse Priced at: $42.70 11M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BCTX X BCTX BriaCell IPO Managers: ThinkEquity Priced at: $4.25 5.88M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BFRA X BFRA Biofrontera Secondary Managers: Benchmark, LAKE Priced at: $6.68 1.334M Shares FRPT X FRPT Freshpet Secondary Managers: BofA, Baird & Truist Priced at: $143.00 2.1M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CELC X CELC Celcuity Spot Secondary Managers: Craig-Hallum Priced at: $14.00 1.714M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	SCR X SCR Score Media Secondary Managers: Morgan Stanley, Credit Suisse, Canaccord & Macquarie Priced at: $27.00 6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial TROX X TROX Tronox Secondary Managers: JPMorgan, BofA, Deutsche Bank, Morgan Stanley Priced at: $18.25 19.11M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ADMS X ADMS Adamas Pharmaceuticals Spot Secondary Managers: SVB Leerink, William Blair & JMP Securities Priced at: $4.40 12.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial APEI X APEI American Public Education Spot Secondary Managers: Truist & William Blair Priced at: $25.00 3.2M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial GPRE X GPRE Green Plains Spot Secondary Managers: Jefferies & BofA Priced at: $23.00 7.6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial IFRX X IFRX InflaRx Spot Secondary Managers: Guggenheim & Raymond James Priced at: $5.00 15M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ITP X ITP IT Tech Packaging Spot Secondary Managers: Maxim Priced at: $.75 26.667M Shares RCEL X RCEL Avita Medical Spot Secondary Managers: Piper Sandler & Cowen Priced at: $21.50 2.795M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	No deals
Wed	APAM X APAM Artisan Partners Spot Secondary Managers: BofA $49.38 1.11M Shares
Thurs	GTES X GTES Gates Industrial Secondary Managers: Citi & Evercore ISI, Barclays, Credit Suisse, Goldman Sachs, Morgan Stanley, RBC Capital, UBS, Baird, Nomura, Wells Fargo, Guggenheim, KeyBanc $17.87 22M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

View All Syndicate Announcements »

BeyondSpring reports Q3 EPS (37c), consensus (54c)

TODAY'S FREE FLY STORIES

Get Full Fly Access